title: Recent advances in hematology: an update from the 16th Congress of the EHA.
abstract: The burden of hematological disorders on healthcare providers is reaching a new peak as the population continues to age, making current research and debate in hematology arguably of greater importance than ever before. At the 16th Congress of the European Hematology Association in London, UK, the latest advances in research, and their associated clinical implications, were highlighted. This article provides a brief overview of a selection of presentations taken from the extensive program.
authors.affiliation: Expert Reviews Ltd, Unitec House, 2 Albert Place, London, N3 1QB, UK. t.oneill@expert-reviews.com
authors.forename: Tess
authors.initials: T
authors.lastname: O'Neill
mesh_terms: D001778:Blood Coagulation Disorders / Q000188:drug therapy; D002471:Cell Transformation, Neoplastic / Q000235:genetics; D017277:Drug Approval; D006405:Hematology / Q000639:trends*; D006706:Homeostasis / Q000235:genetics; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy; D010344:Patient Advocacy